126 related articles for article (PubMed ID: 38097533)
1. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
Cirulli GO; Corsi N; Rakic I; Stephens A; Chiarelli G; Finati M; Davis M; Tinsley S; Sood A; Buffi N; Lughezzani G; Carrieri G; Salonia A; Briganti A; Montorsi F; Rogers C; Abdollah F
BJU Int; 2024 May; 133(5):555-563. PubMed ID: 38097533
[TBL] [Abstract][Full Text] [Related]
2. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
[TBL] [Abstract][Full Text] [Related]
3. Open versus minimally invasive nephroureterectomy in octogenarians: An analysis of surgical approach trends, outcomes, and survival analysis with propensity matching.
Trecarten S; Bhandari M; Abdelaziz A; Noel O; Liss M; Dursun F; Svatek R; Mansour AM
Urol Oncol; 2024 Jul; 42(7):220.e9-220.e19. PubMed ID: 38631967
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: A nationwide cohort analysis.
Rakic I; Rakic N; Stephens A; Corsi N; Davis M; Tinsley S; Butaney M; Arora S; Sood A; Autorino R; Rogers C; Abdollah F
Urol Oncol; 2023 Oct; 41(10):435.e1-435.e9. PubMed ID: 37625905
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
7. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
[TBL] [Abstract][Full Text] [Related]
8. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
[TBL] [Abstract][Full Text] [Related]
9. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
10. Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study.
Narita C; Urabe F; Fukuokaya W; Iwatani K; Imai Y; Yasue K; Mori K; Aikawa K; Yanagisawa T; Kimura S; Tashiro K; Tsuzuki S; Yamada Y; Yuen SKK; Teoh JY; Shimomura T; Yamada H; Furuta A; Miki J; Kimura T;
Clin Genitourin Cancer; 2024 Jun; 22(3):102082. PubMed ID: 38641443
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
Morra S; Incesu RB; Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Creta M; Califano G; Collà Ruvolo C; Saad F; Shariat SF; Chun FKH; de Cobelli O; Musi G; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
World J Urol; 2024 May; 42(1):343. PubMed ID: 38775841
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Adjuvant Chemotherapy in Variant Histology Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Stabilized Inverse Probability Treatment Weighting Analysis of Single Center Experience.
Park I; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Ahn H; Cho YM; Lee J; Hong B
Clin Genitourin Cancer; 2024 Jun; 22(3):102069. PubMed ID: 38580522
[TBL] [Abstract][Full Text] [Related]
13. Postoperative and Survival Outcomes After Cytoreductive Surgery in the Treatment of Metastatic Upper Tract Urothelial Carcinoma.
Pollock G; Hsu CH; Batai K; Lee BR; Chipollini J
Urology; 2021 Jul; 153():244-249. PubMed ID: 33482133
[TBL] [Abstract][Full Text] [Related]
14. The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Jan HC; Wu KY; Tai TY; Weng HY; Yang WH; Ou CH; Hu CY
Cancer Manag Res; 2022; 14():3139-3149. PubMed ID: 36386553
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
[TBL] [Abstract][Full Text] [Related]
16. The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.
Stangl-Kremser J; Muto G; Grosso AA; Briganti A; Comperat E; Di Maida F; Montironi R; Remzi M; Pradere B; Soria F; Albisinni S; Roupret M; Shariat SF; Minervini A; Teoh JY; Moschini M; Cimadamore A; Mari A;
Urol Oncol; 2022 Jun; 40(6):243-261. PubMed ID: 35241364
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
18. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
[TBL] [Abstract][Full Text] [Related]
19. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.
Moschini M; Zamboni S; Afferi L; Pradere B; Abufaraj M; Soria F; D'Andrea D; Roupret M; De la Taille A; Simeone C; Mattei A; Mathieu R; Bensalah K; Wirth MP; Montorsi F; Briganti A; Gallina A; Simone G; Gallucci M; Di Bona C; Marra G; Mari A; Di Trapani E; Alvarez Maestro M; Krajewski W; Shariat SF; Xylinas E; Baumeister P
Arab J Urol; 2020 Sep; 19(1):31-36. PubMed ID: 33763246
[TBL] [Abstract][Full Text] [Related]
20. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma.
Ma Z; Yi Y; Qiu Z
Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
